SCHEMBL206602

SCHEMBL206602

O=C(O)c1ccc(Nc2nc(-c3cc(O)ccc3O)cs2)cc1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 9/20 0.84
AMY1A P0DUB6 5/20 0.84
TYR P14679 2/20 0.84
PIM1 P11309 1/20 0.65
MEN1 O00255 2/20 0.60
MAPT P10636 2/20 0.60
KMT2A Q03164 2/20 0.60
NPC1 O15118 2/20 0.60
RAB9A P51151 2/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
HPGDS O60760 1/20 0.58
VCP P55072 2/20 0.58
KDM4E B2RXH2 1/20 0.58
POLB P06746 1/20 0.58
GAA P10253 1/20 0.58
HPGD P15428 1/20 0.58
GFER P55789 1/20 0.58
CSNK2A2 P19784 1/20 0.57
CSNK2B P67870 1/20 0.57
CSNK2A3 Q8NEV1 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2703774 0.91 AMY1A (1.00) CSNK2A1AMY1ATYRPIM1MEN1
SCHEMBL205697 0.82 MEN1 (0.84) CSNK2A1AMY1ATYRMEN1MAPT
SCHEMBL1818544 0.77 CSNK2A1 (1.00) CSNK2A1AMY1ATYRMEN1MAPT
SCHEMBL12295951 0.77 AMY1A (0.84) CSNK2A1AMY1ATYRPIM1MEN1
SCHEMBL11887633 0.73 CSNK2A1 (0.78) CSNK2A1AMY1AMEN1MAPTKMT2A
SCHEMBL13401539 0.73 CSNK2A1 (0.78) CSNK2A1AMY1ATYRMEN1MAPT
SCHEMBL12692367 0.73 CSNK2A1 (0.71) CSNK2A1AMY1ATYRMEN1MAPT
SCHEMBL2706374 0.73 MAPT (1.00) CSNK2A1AMY1ATYRPIM1MEN1
SCHEMBL3602981 0.73 TYR (0.54) CSNK2A1AMY1ATYRMEN1MAPT
SCHEMBL18543638 0.72 TYR (1.00) CSNK2A1AMY1ATYRPIM1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE PIGS, CPT1A, SLC10A1 CSNK2A1 1577/4885AMY1A 527/4885TYR 3275/4885
US-20070004711-A1 Thiazole compounds and methods of use PIGS, CPT1A, SLC10A1 CSNK2A1 1577/4885AMY1A 527/4885TYR 3275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.